technetium (99mTc) fanolesomab
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
radiopharmaceutical |
| gptkbp:approvalYear |
2004
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:contains |
gptkb:technetium-99m
fanolesomab |
| gptkbp:developedBy |
gptkb:Palatin_Technologies
|
| https://www.w3.org/2000/01/rdf-schema#label |
technetium (99mTc) fanolesomab
|
| gptkbp:indication |
imaging of patients with suspected appendicitis
|
| gptkbp:macromoleculeType |
murine IgM monoclonal antibody
|
| gptkbp:marketedAs |
gptkb:NeutroSpec
|
| gptkbp:retired |
serious adverse reactions
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
death
anaphylaxis hypotension cardiorespiratory arrest |
| gptkbp:target |
CD15 antigen
|
| gptkbp:usedFor |
diagnostic imaging
detection of infection |
| gptkbp:withdrawn |
2005
|
| gptkbp:bfsParent |
gptkb:NeutroSpec
|
| gptkbp:bfsLayer |
8
|